Salix Pharmaceuticals Ltd, Cosmo deal
Salix will merge with an Irish subsidiary of partner Cosmo in a stock deal that will give Cosmo about a 20% stake in Salix. Salix will become a subsidiary of the Irish subsidiary, Cosmo Technologies Ltd., which will list on NASDAQ and